| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.5 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |